Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 46,498 | 17,010 | 13,147 | 3,760 | 0 |
| Cost of Goods | 529 | 770 | 502 | 121 | N/A |
| Gross Profit | 45,969 | 16,240 | 12,645 | 3,639 | N/A |
| Operating Expenses | 86,862 | 79,791 | 70,939 | 74,242 | 70,665 |
| Operating Income | -40,364 | -62,781 | -57,792 | -70,482 | -70,665 |
| Interest Expense | 9,217 | 9,520 | 4,265 | 2,555 | 2,000 |
| Other Income | 31,750 | 15,949 | -9,347 | 708 | 21,245 |
| Pre-tax Income | -17,831 | -56,352 | -71,404 | -72,329 | -51,420 |
| Income Tax | -1,170 | -21,971 | 145 | 240 | 107 |
| Net Income Continuous | -16,661 | -34,381 | -71,549 | -72,569 | -51,527 |
| Net Income | $-16,661 | $-34,381 | $-71,549 | $-72,569 | $-51,527 |
| EPS Basic Total Ops | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
| EPS Basic Continuous Ops | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
| EPS Diluted Total Ops | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
| EPS Diluted Continuous Ops | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
| EBITDA(a) | $-39,770 | $-62,022 | $-57,134 | $-69,847 | $-70,087 |